← Back to Search

Screening Strategies for Breast Cancer Detection

N/A
Recruiting
Led By Jeremy M Wolfe, PhD
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age over 18 yrs
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights

Study Summary

This trial looked at whether it is better to ask observers to search for simulated masses and calcs separately or together.

Who is the study for?
This trial is for individuals over 18 years old with normal color vision and at least 20/25 corrected visual acuity. It's not suitable for those with a history of neuromuscular or visual disorders.Check my eligibility
What is being tested?
The study tests different methods of breast cancer screening in a simulated environment, comparing the effectiveness of searching only for masses or calcifications versus looking for both simultaneously or one after another.See study design
What are the potential side effects?
Since this trial involves non-invasive simulated mammography tasks without medical interventions, there are no direct side effects associated with the procedures being tested.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rates of false positive and false negative errors
Time required to respond to a case

Trial Design

2Treatment groups
Experimental Treatment
Group I: Mixed TrialsExperimental Treatment4 Interventions
There are four conditions in the experiment. All condition will be presented, randomly mixed in a single block of 400 trials (with breaks every 100 trials).
Group II: Blocked TrialsExperimental Treatment4 Interventions
There are four conditions in the experiment. Each condition will be presented in a separate block of 100 trials.

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor
1,616 Previous Clinical Trials
11,470,878 Total Patients Enrolled
Jeremy M Wolfe, PhDPrincipal InvestigatorBrigham and Women's Hospital
3 Previous Clinical Trials
1,191 Total Patients Enrolled

Media Library

Mixed Trials Clinical Trial Eligibility Overview. Trial Name: NCT05975736 — N/A
Mammogram Research Study Groups: Mixed Trials, Blocked Trials
Mammogram Clinical Trial 2023: Mixed Trials Highlights & Side Effects. Trial Name: NCT05975736 — N/A
Mixed Trials 2023 Treatment Timeline for Medical Study. Trial Name: NCT05975736 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this clinical experiment open to new participants?

"Affirmative. Clinicaltrials.gov's data implies that this clinical trial is currently recruiting patients, with enrollment commencing on September 1st 2022 and the most recent update being done August 2nd 2023. This study requires 70 individuals to be recruited at a single site."

Answered by AI

How many participants are being recruited for this trial?

"Affirmative. Evident from the information on clinicaltrials.gov, this scientific trial is actively enrolling patients. This research was first published on September 1st 2022 and has been updated most recently as of August 2nd 2023; 70 participants are required at a single site to complete the study."

Answered by AI
~47 spots leftby Sep 2027